Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Strategies for Assessing and Addressing Confounding

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

Confounding in Epidemiological Studies

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Using a translational data platform to create clinical-grade genome-informed risk assessments.

JAMIA open·2026

Same author

Opioid Use Disorder and Treatment Uptake among Patients with Rheumatic Conditions in the All of Us Research Program: A Descriptive Analysis.

Arthritis care & research·2026

Same author

A blended genome and exome sequencing method captures genetic variation in an unbiased and cost-effective manner.

Nature genetics·2026

Same author

Obesity Polygenic Risk and Healthy Lifestyle Interactions on Weight Trajectories in Women and Men.

Journal of the American Heart Association·2026

Same author

Long-term Penetrance of Disease Variants in Genes Prioritized for Genomic Newborn Screening: Evidence from Adult Biobanks.

medRxiv : the preprint server for health sciences·2026

Same author

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

JACC. Advances·2026

Search research articles

Related Experiment Video

Updated: Apr 6, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Assessing incremental value of biomarkers with multi-phase nested case-control studies.

Qian M Zhou¹, Yingye Zheng², Lori B Chibnik³

¹Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, Canada, V5A1S6.

|July 22, 2015

Summary

This study introduces new statistical methods for rheumatoid arthritis (RA) risk prediction using novel biomarkers. The approach enhances existing models by evaluating the incremental value of these markers in complex nested case-control designs.

Keywords:

Incremental value Inverse probability weighting Nested case-control study Rheumatoid arthritis Risk prediction Time dependent ROC curve analysis

More Related Videos

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Related Experiment Videos

Last Updated: Apr 6, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Area of Science:

Epidemiology
Biostatistics
Rheumatology

Background:

Accurate rheumatoid arthritis (RA) risk prediction is crucial for personalized prevention and treatment.
Existing risk models may not fully incorporate the value of novel biomarkers and genetic markers.
The Nurses' Health Study provides a valuable dataset for investigating these associations.

Purpose of the Study:

To develop robust statistical procedures for constructing RA risk prediction models using three-phase nested case-control (NCC) studies.
To estimate the incremental value (IncV) of new biomarkers in improving existing RA risk prediction models.
To account for potential time-varying effects of biomarkers in risk modeling for short-term and long-term prediction.

Main Methods:

Utilized a three-phase nested case-control (NCC) design within the Nurses' Health Study.
Developed statistical procedures for risk model construction and incremental value estimation.
Incorporated methods to assess time-varying biomarker effects on RA risk.

Main Results:

The study proposes novel statistical procedures for RA risk prediction.
The methods are designed to evaluate the incremental value of new biomarkers.
Simulation studies demonstrated the good performance of the proposed procedures in finite samples.

Conclusions:

The developed statistical procedures offer a robust approach to RA risk prediction.
The methods effectively estimate the incremental value of novel biomarkers.
The approach allows for a more nuanced assessment of biomarker utility over different time horizons.